Tooth decay, also known as dental caries or cavities, is when the teeth are broken down due to the acids made by bacteria from food and sugar. Currently, the Pharma Intelligence Center database covers clinical trials that include tooth decay and provides many key analyses, including trial status, phase, and location.

When looking at these clinical trials, it can be said that the majority have been completed (72.7%), with ongoing clinical trials following (17.7%) (Figure 1). Also, over 91% of tooth decay clinical trials are in late-stage trial phases, with 48.3% in Phase II, 21.4% in Phase III, and 21.8% in Phase IV (Figure 2). Lastly, based on location, the US and India have the most clinical trials (18.5% and 11.8%). Brazil, Iran, Thailand, China, Egypt, Germany, the UK, and Australia round out the top 10 countries with tooth decay clinical trials (Figure 3).

Figure 1: tooth decay clinical trials, by trial status

Source: GlobalData, Pharma Intelligence Center

Figure 2: tooth decay clinical trials, by trial phase

Source: GlobalData, Pharma Intelligence Center

Figure 3: tooth decay clinical trials, by location

Source: GlobalData, Pharma Intelligence Center

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.